Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline.
about
MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African AmericansThe mitogen-activated protein (MAP) kinases p38 and extracellular signal-regulated kinase (ERK) are involved in hepatocyte-mediated phenotypic switching in prostate cancer cellsE-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas.Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient.Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells.Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance.Prostate tumor cell plasticity: a consequence of the microenvironment.Detecting gene-gene interactions in prostate disease in African American menCo-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin.Liver protects metastatic prostate cancer from induced death by activating E-cadherin signaling.
P2860
Q27008271-731198CB-4090-421B-B8E4-33BA6755B34FQ33676246-FE680D8E-331C-4454-9911-2CD0B4BB6761Q34088774-890FE0F1-8C17-4111-85A9-7B63E69C6214Q34486740-10D61B70-E564-4620-B50F-DC049CBF7592Q35094512-4EE6B5AB-2F8B-48E2-838A-DE0916F353C6Q36272854-67385BDF-399B-4832-83B1-C472DD7F44BDQ36355677-A9FEEF5D-BD72-4541-9837-C368649574E8Q37709855-4B05B504-48A8-4729-9428-1AE4A2A80DD9Q37929041-F14ED590-3101-406F-8F66-DC7EC1A95772Q38716005-4D104952-AB65-4C24-8CBA-631CE3368E39Q40150065-C7503235-2CD6-40B8-A567-DBBF9B68F8C7Q42713706-1786A519-658A-4422-A616-3696FC9A403A
P2860
Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Luteinising hormone-releasing ...... an prostate carcinoma subline.
@ast
Luteinising hormone-releasing ...... an prostate carcinoma subline.
@en
type
label
Luteinising hormone-releasing ...... an prostate carcinoma subline.
@ast
Luteinising hormone-releasing ...... an prostate carcinoma subline.
@en
prefLabel
Luteinising hormone-releasing ...... an prostate carcinoma subline.
@ast
Luteinising hormone-releasing ...... an prostate carcinoma subline.
@en
P2093
P2860
P356
P1476
Luteinising hormone-releasing ...... an prostate carcinoma subline.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602350
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1017665647